Showing results (321-330 of 552) with videos related to
Sort By:
Pageof 56
Pharmacology Research & Perspectives|March 7, 2024
Adherence to newer second-line oral antidiabetic drugs among people with type 2 diabetes-A systematic reviewNynne Sophie Holdt-Caspersen, Claus Dethlefsen, Peter Vestergaard, et al.Clinical Epidemiology|October 14, 2024
Incidence of Graves' Disease with Validation and Completeness of the Diagnosis for Registry Extracts in the Danish National Patient RegisterFrederik Østergaard Klit, Jakob Dal, Stine Linding Andersen, et al.Diabetes Research and Clinical Practice|April 19, 2025
Assessment of basal insulin adherence in people with type 2 diabetes in telemonitoring: Post-hoc analysis of novel data modalities including insulin injection dataJannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, et al.Journal of Diabetes Science and Technology|December 23, 2022
Time for Using Machine Learning for Dose Guidance in Titration of People With Type 2 Diabetes? A Systematic Review of Basal Insulin Dose GuidanceCamilla Heisel Nyholm Thomsen, Stine Hangaard, Thomas Kronborg, et al.Diabetes Technology & Therapeutics|September 2, 2025
Biases in Glucose Metrics Are Directly Related to Low Coverage of Continuous Glucose Monitoring: Insights from Diverse PopulationsSimon Lebech Cichosz, Niels Væver Hartvig, Thomas Kronborg, et al.Journal of Diabetes Science and Technology|December 29, 2023
A Three-Step Data-Driven Methodology to Assess Adherence to Basal Insulin Therapy in Patients With Insulin-Treated Type 2 DiabetesJannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 7, 2017
Longer term effectiveness of inpatient multidisciplinary rehabilitation on health-related quality of life in MS patients: a pragmatic randomized controlled trial - The Danish MS Hospitals Rehabilitation StudyFinn Boesen, Michael Nørgaard, Philipp Trénel, et al.Journal of Diabetes Science and Technology|May 28, 2020
Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 DiabetesMorten Hasselstrøm Jensen, Simon Lebech Cichosz, Irl B Hirsch, et al.Plos One|April 11, 2015
Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panelMorten Stilund, Mikkel Carstensen Gjelstrup, Thor Petersen, et al.Journal of Diabetes|March 26, 2025
Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry-Based Case-Control StudyAsger Ahlmann Bech, Mia Daugaard Madsen, Annika Vestergaard Kvist, et al.Pageof 56